Design of nanoparticles as drug carriers for cancer therapy

Download
  1. Get@NRC: Design of nanoparticles as drug carriers for cancer therapy (Opens in a new window)
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleCancer Genomics and Proteomics
Volume3
Issue3-4
Pages147157; # of pages: 11
SubjectDrug delivery; cancer chemotherapy; nanoparticles; polymer- and liposome-systems; magnetic nanohybrids; review
AbstractThis review explores the recent chemotherapeutic work on drug delivery using nanoparticles as carriers for the targeted treatment of cancer. Compared to direct drug delivery, delivery through a carrier can increase the efficacy of a drug, but decrease the side-effects by utilizing the enhanced permeability and retention (EPR) effect and tumor-specific targeting. The search for efficient and safe transport vehicles (carriers) to achieve better drug availability at the target site has been a challenging yet exciting area of research. Current interest focuses on the colloidal nanoparticles (diameter <500 nm), including the biodegradable polymer- and liposome-systems, bioconjugating with antitumor drugs. These biocompatible nanoparticles, with an enlarged surface area-volume ratio can overcome non-cellular and cellular-based mechanisms of resistance and increase the selectivity of drugs towards cancer cells, while reducing their toxicity towards normal tissues. This review focuses on the evolution of nanoparticles as carriers for anticancer drug delivery, with emphasis on the biocompatible magnetic nanohybrids.
Publication date
LanguageEnglish
AffiliationNational Research Council Canada; NRC Institute for Chemical Process and Environmental Technology; NRC Steacie Institute for Molecular Sciences
Peer reviewedYes
NRC number52261
NPARC number12328989
Export citationExport as RIS
Report a correctionReport a correction
Record identifierf72fab1a-b091-4e63-9e33-d3d4810ab39f
Record created2009-09-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)